Resources from the same session
Why do we need to understand PK curves, halflives and AUCs in early drug development?
Presenter: Shelby Barnett
Session: Workshop in collaboration with ESMO YOC: Basics on PKs
Resources:
Slides
Webcast
Do we need to adjust dosing of oncolytics for young, elderly, obese, bariatric surgery, … patients?
Presenter: Tim Schutte
Session: Workshop in collaboration with ESMO YOC: Basics on PKs
Resources:
Slides
Webcast